1.20
+0.02(+1.69%)
Currency In USD
| Previous Close | 1.18 |
| Open | 1.19 |
| Day High | 1.23 |
| Day Low | 1.18 |
| 52-Week High | 1.66 |
| 52-Week Low | 0.28 |
| Volume | 1.47M |
| Average Volume | 1.82M |
| Market Cap | 436.08M |
| PE | -6.32 |
| EPS | -0.19 |
| Moving Average 50 Days | 1.31 |
| Moving Average 200 Days | 1.05 |
| Change | 0.02 |
If you invested $1000 in Lexicon Pharmaceuticals, Inc. (LXRX) 10 years ago, it would be worth $113.42 as of January 14, 2026 at a share price of $1.2. Whereas If you bought $1000 worth of Lexicon Pharmaceuticals, Inc. (LXRX) shares 5 years ago, it would be worth $149.07 as of January 14, 2026 at a share price of $1.2.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Lexicon Pharmaceuticals Provides a Business and Pipeline Update at the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 12, 2026 12:30 PM GMT
SONATA-HCM on track for enrollment completion in 2026 and topline data in 2027 $10 million milestone payment triggered from licensing agreement with Novo Nordisk for LX9851 Zynquista on track for NDA resubmission and potential approval in 2026 Compan
Lexicon Pharmaceuticals Publishes “Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain”
GlobeNewswire Inc.
Jan 09, 2026 1:30 PM GMT
-White Paper based on October 2025 Roundtable of diverse stakeholders focused on accelerating innovation and expanding access to novel non-opioid therapies- -Need for swift action by policymakers to support millions of Americans suffering from chroni
Lexicon Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 07, 2026 1:30 PM GMT
THE WOODLANDS, Texas, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, January 15 at 12:00 p.m. PT